Fish Oil and Adaptations to Resistance Exercise in Older People
Overcoming the Blunted Response to Resistance Exercise With Fish Oil to Maximise Musculoskeletal Properties and Functional Abilities in Older People
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aberdeen, United Kingdom, G12 8TA
- University of Aberdeen
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 65 years of age
- Not consuming oily fish regularly
- Not consuming nutritional supplements
- Not participating in resistance exercise training
Exclusion Criteria:
- History of myocardial infarction within previous 2 years
- Cardiac illness: moderate/ severe aortic stenosis, acute pericarditis, acute myocarditis, aneurysm, severe angina, clinically significant valvular disease, uncontrolled dysrhythmia, claudication within the previous 10 years
- Thrombophlebitis or pulmonary embolus within the previous 2 years
- History of cerebrovascular disease (CVA or TIA) within the previous 2 years
- Acute febrile illness within the previous 3 months
- Severe airflow obstruction
- Uncontrolled metabolic disease (e.g., thyroid disease or cancer)
- Significant emotional distress, psychotic illness or depression within the previous 2 years
- Lower limb fracture sustained within the previous 2 years; upper limb fracture within the previous 6 months; non arthroscopic lower limb joint surgery within the previous 2 years
- Any reason for loss of mobility for greater than 1 week in the previous 2 months or greater than 2 weeks in the previous 6 months
- Poorly controlled atrial fibrillation
- Poor (chronic) pain control
- Resting systolic pressure >200 mmHg or resting diastolic pressure >100 mmHg
- Moderate/ severe cognitive impairment (MMSE <23)
- Impaired tissue viability (defined by a Waterlow risk assessment score >15).
Based on Greig C.A. et al. Age Ageing 1994, 23: 185-9
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Safflower Oil plus Resistance Exercise Training
3.0g of safflower oil taken daily alongside twice weekly resistance exercise training sessions for 18 weeks
|
Resistance exercise will involve 2 sessions per week for 18 weeks.
Each session will involve participants carrying out the following exercises: calf press, leg press, leg extension and leg curl
Participants randomised to either 3g/day of fish oil or safflower oil for 18 weeks
|
|
Active Comparator: Fish Oil plus Resistance Exercise Training
3.0g of fish oil taken daily alongside twice weekly resistance exercise training sessions for 18 weeks
|
Resistance exercise will involve 2 sessions per week for 18 weeks.
Each session will involve participants carrying out the following exercises: calf press, leg press, leg extension and leg curl
Participants randomised to either 3g/day of fish oil or safflower oil for 18 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Maximal Isometric Knee Extensor Torque
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Short Performance Physical Battery Test
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
|
Maximal Isokinetic Knee Extensor Torque (30,90 and 120 degrees/s)
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
|
Quadriceps Cross Sectional Area (MRI)
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
|
Circulating markers of inflammation (IL-6 and TNF-alpha)
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
|
Muscle protein synthesis
Time Frame: 18 weeks
|
18 weeks
|
|
Muscle P70s6k activity
Time Frame: Change from baseline to 2h post-exercise
|
Change from baseline to 2h post-exercise
|
|
Erythrocyte fatty acid composition
Time Frame: Change from baseline at 18 weeks
|
Change from baseline at 18 weeks
|
|
Muscle membrane fatty acid composition
Time Frame: 18 weeks
|
18 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Da Boit M, Tommasi S, Elliot D, Zinellu A, Sotgia S, Sibson R, Meakin JR, Aspden RM, Carru C, Mangoni AA, Gray SR. Sex Differences in the Associations between L-Arginine Pathway Metabolites, Skeletal Muscle Mass and Function, and their Responses to Resistance Exercise, in Old Age. J Nutr Health Aging. 2018;22(4):534-540. doi: 10.1007/s12603-017-0964-6.
- Da Boit M, Sibson R, Sivasubramaniam S, Meakin JR, Greig CA, Aspden RM, Thies F, Jeromson S, Hamilton DL, Speakman JR, Hambly C, Mangoni AA, Preston T, Gray SR. Sex differences in the effect of fish-oil supplementation on the adaptive response to resistance exercise training in older people: a randomized controlled trial. Am J Clin Nutr. 2017 Jan;105(1):151-158. doi: 10.3945/ajcn.116.140780. Epub 2016 Nov 16.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Gray BBSRC NI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.